Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Supernus Pharmaceuticals, Inc. SUPN

Full chart Compare
Set alert

Price alert · SUPN

All alert types
27.48 USD -0.67 (-2.38%)

Nov 4, 2026, 10:13 AM EST

26.74 Day range 28.99
26.74 52-week range 59.68
YTD
-23.41%
1 year
-14.12%

Financial health

Altman Z-Score

2.45 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

7 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

B-3 / 5 overall

  • DCF 5
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 3

Valuation

P/E 21.4×
FY 2016: 80.7×FY 2017: 65.5×FY 2018: 3.7×FY 2019: 2.7×FY 2020: -6.8×FY 2021: 12.5×FY 2022: -58.8×FY 2023: -16.2×FY 2024: 823×FY 2025: 21.4×
FY 2016 5y median 12.5× FY 2025
P/S 3.6×
FY 2016: 2.6×FY 2017: 3.5×FY 2018: 1.0×FY 2019: 0.5×FY 2020: 1.7×FY 2021: 3.2×FY 2022: 3.4×FY 2023: 1.9×FY 2024: 1.4×FY 2025: 3.6×
FY 2016 5y median 3.2× FY 2025
P/B -45.8×
FY 2016: -8.7×FY 2017: -19.5×FY 2018: 14.9×FY 2019: 1.8×FY 2020: 13.1×FY 2021: 12.4×FY 2022: 59.0×FY 2023: -11.0×FY 2024: -4.7×FY 2025: -45.8×
FY 2016 5y median -4.7× FY 2025
P/FCF -47.7×
FY 2016: 6.9×FY 2017: 15.7×FY 2018: 3.7×FY 2019: 2.6×FY 2020: -5.5×FY 2021: 7.9×FY 2022: -336×FY 2023: -5.9×FY 2024: 328×FY 2025: -47.7×
FY 2016 5y median -5.9× FY 2025
EV/EBITDA 15.3×
FY 2016: 15.9×FY 2017: 17.4×FY 2018: 1.0×FY 2019: -1.7×FY 2020: -4.1×FY 2021: 7.1×FY 2022: -54.8×FY 2023: -20.8×FY 2024: 20.4×FY 2025: 15.3×
FY 2016 5y median 7.1× FY 2025
EV/Sales 3.7×
FY 2016: 2.5×FY 2017: 3.1×FY 2018: 0.3×FY 2019: -0.5×FY 2020: 0.8×FY 2021: 2.1×FY 2022: 2.8×FY 2023: 1.9×FY 2024: 1.4×FY 2025: 3.7×
FY 2016 5y median 2.1× FY 2025
FCF Yield -2.1%
FY 2016: 14.6%FY 2017: 6.4%FY 2018: 26.7%FY 2019: 37.9%FY 2020: -18.3%FY 2021: 12.7%FY 2022: -0.3%FY 2023: -16.8%FY 2024: 0.3%FY 2025: -2.1%
FY 2016 5y median -0.3% FY 2025

Profitability

Gross Margin 80.1%
FY 2016: 88.6%FY 2017: 89.3%FY 2018: 86.0%FY 2019: 82.2%FY 2020: 85.0%FY 2021: 83.9%FY 2022: 83.2%FY 2023: 84.1%FY 2024: 80.6%FY 2025: 80.1%
FY 2016 5y median 83.2% FY 2025
Operating Margin 21.4%
FY 2016: 34.9%FY 2017: 36.9%FY 2018: 33.0%FY 2019: 22.7%FY 2020: -24.1%FY 2021: 26.9%FY 2022: -9.0%FY 2023: -14.3%FY 2024: 2.7%FY 2025: 21.4%
FY 2016 5y median 2.7% FY 2025
Net Margin 16.9%
FY 2016: 3.3%FY 2017: 5.3%FY 2018: 27.4%FY 2019: 17.1%FY 2020: -22.9%FY 2021: 25.9%FY 2022: -4.9%FY 2023: -11.8%FY 2024: 0.2%FY 2025: 16.9%
FY 2016 5y median 0.2% FY 2025
ROE -214.3%
FY 2016: -10.9%FY 2017: -30.0%FY 2018: 398.0%FY 2019: 64.1%FY 2020: -180.5%FY 2021: 101.0%FY 2022: -85.8%FY 2023: 67.5%FY 2024: -0.6%FY 2025: -214.3%
FY 2016 5y median -0.6% FY 2025
ROIC 70.8%
FY 2016: 43.1%FY 2017: 30.1%FY 2018: 42.8%FY 2019: 14.4%FY 2020: -14.1%FY 2021: 20.5%FY 2022: -5.4%FY 2023: -27.7%FY 2024: 1.7%FY 2025: 70.8%
FY 2016 5y median 1.7% FY 2025
ROA 17.4%
FY 2016: 2.7%FY 2017: 4.2%FY 2018: 17.0%FY 2019: 8.1%FY 2020: -9.7%FY 2021: 11.2%FY 2022: -2.5%FY 2023: -7.3%FY 2024: 0.2%FY 2025: 17.4%
FY 2016 5y median 0.2% FY 2025

Growth (YoY)

Revenue 4.3%
FY 2016: 0.0%FY 2017: 18.5%FY 2018: -16.4%FY 2019: -18.2%FY 2020: -17.6%FY 2021: 22.3%FY 2022: 13.9%FY 2023: 21.3%FY 2024: 8.7%FY 2025: 4.3%
FY 2016 FY 2025
Operating Income 728.1%
FY 2016: 0.0%FY 2017: 25.3%FY 2018: -25.1%FY 2019: -43.9%FY 2020: -187.6%FY 2021: 236.5%FY 2022: -138.0%FY 2023: -92.6%FY 2024: 120.5%FY 2025: 728.1%
FY 2016 FY 2025
EPS (diluted) 10833.3%
FY 2016: 0.0%FY 2017: 86.4%FY 2018: 326.8%FY 2019: -47.4%FY 2020: -217.4%FY 2021: 221.3%FY 2022: -128.2%FY 2023: -145.9%FY 2024: 101.6%FY 2025: 10833.3%
FY 2016 FY 2025
Free Cash Flow -1980.0%
FY 2016: 0.0%FY 2017: -32.3%FY 2018: 4.0%FY 2019: -45.0%FY 2020: -236.8%FY 2021: 261.9%FY 2022: -102.8%FY 2023: -3822.2%FY 2024: 101.4%FY 2025: -1980.0%
FY 2016 FY 2025

Financial Health

Current Ratio 0.7×
FY 2016: 1.0×FY 2017: 1.4×FY 2018: 1.6×FY 2019: 1.8×FY 2020: 2.0×FY 2021: 1.8×FY 2022: 1.2×FY 2023: 1.0×FY 2024: 0.9×FY 2025: 0.7×
FY 2016 5y median 1.0× FY 2025
Quick Ratio 0.5×
FY 2016: 0.9×FY 2017: 1.4×FY 2018: 1.5×FY 2019: 1.7×FY 2020: 1.8×FY 2021: 1.7×FY 2022: 1.1×FY 2023: 0.9×FY 2024: 0.7×FY 2025: 0.5×
FY 2016 5y median 0.9× FY 2025
Debt / Equity -3.6×
FY 2016: -1.8×FY 2017: -2.4×FY 2018: 3.7×FY 2019: 1.4×FY 2020: 3.5×FY 2021: 1.4×FY 2022: 5.4×FY 2023: -1.5×FY 2024: -1.1×FY 2025: -3.6×
FY 2016 5y median -1.1× FY 2025
Net Debt / EBITDA 0.5×
FY 2016: -1.0×FY 2017: -1.8×FY 2018: -2.2×FY 2019: -3.3×FY 2020: 4.7×FY 2021: -3.4×FY 2022: 10.9×FY 2023: 0.3×FY 2024: 0.7×FY 2025: 0.5×
FY 2016 5y median 0.5× FY 2025
Interest Coverage 5.9×
FY 2016: 6.6×FY 2017: 8.6×FY 2018: 10.2×FY 2019: 8.1×FY 2020: -6.5×FY 2021: 8.2×FY 2022: -2.8×FY 2023: -4.5×FY 2024: 0.8×FY 2025: 5.9×
FY 2016 5y median 0.8× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 2.7%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 215.3%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31